GL1X · GenesisL1 explorer

Research workbench

A pharmacological MAP of the PI3-K family defines a role for P110ALPHA in signaling: the structure of complex of phosphoinositide 3-kinase gamma with inhibitor pik-93

Analyse A pharmacological MAP of the PI3-K family defines a role for P110ALPHA in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2CHZ
Type
protein
Length
839 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.137, 2.7.1.153
UniProt
P48736
Ligands
093
Pockets
13 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.137, 2.7.1.153)protein83944% helix, 17% strandP48736

Ligands and binding sites

  • 093 · N-(5-(4-chloro-3-(2-hydroxy-ethylsulfamoyl)- phenylthiazole-2-yl)-acetamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111820.820.8394empty
2660.710.9723empty
34410.690.8045093
43850.650.7939empty
52210.600.8141empty

Compared structures

  • 2CHZ · A pharmacological map of the PI3-K family defines a role for p110alpha in signaling: The… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.